Conecte-se

Bibliografias temáticas / Cancer Radiotherapy / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Cancer Radiotherapy.

Artigos de revistas sobre o tema "Cancer Radiotherapy"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 29 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Cancer Radiotherapy".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Sukarno, Vania, I. Widyadharma, Ida Wijayanti, Kumara Tini, and Ngakan Ganapati. "Pain Characteristics of Cervical Cancer Patient Who Underwent Radiotherapy in Bali, Indonesia." International Journal of Medical Reviews and Case Reports 4, Reports in Microbiology, Infecti (2020): 1. http://dx.doi.org/10.5455/ijmrcr.cervical-cancer-radiotherapy-bali.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Lee, B.-J., S.-G. Wang, H.-J. Roh, E.-K. Goh, K.-M. Chon, and D.-Y. Park. "Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy." Journal of Laryngology & Otology 120, no. 7 (May 4, 2006): 579–82. http://dx.doi.org/10.1017/s0022215106001150.

Texto completo da fonte

Resumo:

The biological changes in recurrent laryngeal cancer following radiotherapy are not fully understood. The authors investigated differences in the expression of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 in laryngeal cancer specimens before radiotherapy and in recurrent laryngeal cancer specimens following radiotherapy in the same patients. The authors investigated the expression of p53, PCNA and bcl-2 by immunohistochemical stain in 30 specimens from 15 patients with primary laryngeal cancer and recurrent laryngeal cancer after radiotherapy.The expression of p53 protein was signi

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Mohamed Traore, Wend-Yam, Behyamet Onka, Ibrahima Dokal Diallo, Rachida Latib, and Youssef Omor. "Post-radiotherapy recto-vaginal fistula in cervical cancer." International Journal of Case Reports and Images 13, no. 2 (October 3, 2022): 153–55. http://dx.doi.org/10.5348/101349z01wt2022ci.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Stepanović, Aleksandar, Tatjana Arsenijevic, Vesna Stankovic, Vukac Vujanac, Anja Lazovic, Tanja Raonic-Stevanovic, and Marina Nikitovic. "Clinical analysis of COVID-19 positive cancer inpatients in National Cancer Center in Serbia." Journal of Infection in Developing Countries 15, no. 09 (September 30, 2021): 1286–92. http://dx.doi.org/10.3855/jidc.15104.

Texto completo da fonte

Resumo:

Introduction: The outbreak of COVID-19 has had an impact on global healthcare as well as on radiotherapy practice in many countries. This study aimed to identify clinical characteristics of Coronavirus Disease 2019 (COVID-19) infected cancer inpatients, as well as what impact this infection had on radiation treatment of the patients. Methodology: In this retrospective study, we included cancer inpatients with laboratory confirmed COVID-19 infection during the radiotherapy or chemoradiation in April 2020 in National Cancer Research Center in Serbia. Data were obtained from the medical rec

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Hsieh, Kristin, Daniel R. Dickstein, Juliana Runnels, Eric J. Lehrer, Kenneth Rosenzweig, Fred R. Hirsch, and Robert M. Samstein. "Radiotherapy and Immunotherapy in Lung Cancer." Biomedicines 11, no. 6 (June 6, 2023): 1642. http://dx.doi.org/10.3390/biomedicines11061642.

Texto completo da fonte

Resumo:

The emergence of immune checkpoint inhibitors (ICIs) as a pillar of cancer treatment has emphasized the immune system’s integral role in tumor control and progression through cancer immune surveillance. ICIs are being investigated and incorporated into the treatment paradigm for lung cancers across stages and histology. To date, definitive concurrent chemoradiotherapy followed by consolidative durvalumab is the only National Comprehensive Cancer Network’s recommended treatment paradigm including radiotherapy with ICI in lung cancers, although there are other recommendations for ICI with chemot

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Pandey, Dr Vivek Kumar. "Prospective Study to Compare Outcomes Following Hypofractionated Radiotherapy versus Conventional Radiotherapy in Carcinoma Breast." Journal of Medical Science And clinical Research 11, no. 07 (July 30, 2023): 15–26. http://dx.doi.org/10.18535/jmscr/v11i7.04.

Texto completo da fonte

Resumo:

Background: Breast cancer is now the most common cancer worldwide (GLOBOCAN, 2020). It is the most common cancer among women in developed countries. The age standardized incidence rate of breast cancer in India is 25.8% per 100,000 women (GLOBOCAN, 2020). By 2020, breast cancer overtook cervical cancer as the most common type of cancer among all women in India. Breast irradiation has been shown to reduce the risk of local recurrence after breast-conserving surgery from about 30% to <10% at 10 years. Aims & Objectives: Randomize Breast carcinoma into two arms - Arm A :- 39GY in 13 fracti

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Manzoor, Najmi Arshad. "Unplanned Interruption of Radiotherapy in Head and Neck Cancers: report from a Regional Cancer Centre." Journal of Medical Science And clinical Research 05, no. 04 (April 14, 2017): 20294–300. http://dx.doi.org/10.18535/jmscr/v5i4.90.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Rovirosa, Angeles, Meritxell Arenas, and Luca Tagliaferri. "Interventional Radiotherapy in Gynecological Cancer." Cancers 15, no. 19 (September 29, 2023): 4804. http://dx.doi.org/10.3390/cancers15194804.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Chandra, Ade, Sukri Rahman, Al Hafiz, Eva Decroli, and Hafni Bachtiar. "Pengaruh Radioterapi Terhadap Kadar TSH dan T4 pada Pasien Tumor Ganas Kepala dan Leher." Oto Rhino Laryngologica Indonesiana 48, no. 2 (January 30, 2019): 159. http://dx.doi.org/10.32637/orli.v48i2.238.

Texto completo da fonte

Resumo:

Latar belakang: Tumor ganas kepala dan leher adalah tumor ganas yang berasal dari epitel traktus aerodigestif atas. Radioterapi adalah salah satu modalitas talaksana pada tumor ganas kepala dan leher. Kelenjar tiroid akan terpapar radioterapi selanjutnya merangsang terjadinya kelainan pada kelenjar tiroid. Hipotiroid merupakan efek samping yang paling umum terjadi akibat radioterapi. Diagnosis hipotiroid ditegakkan melalui pemeriksaan laboratorium yaitu didapatkan peningkatan TSH dan penurunan T4. Tujuan: Mengetahui pengaruh radioterapi terhadap kadar TSH dan T4 pasien tumor ganas kepala dan l

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Shirai, Katsuyuki, Akiko Nakagawa, Takanori Abe, Masahiro Kawahara, Jun-ichi Saitoh, Tatsuya Ohno, and Takashi Nakano. "Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers." International Journal of Molecular Imaging 2012 (May 14, 2012): 1–9. http://dx.doi.org/10.1155/2012/609545.

Texto completo da fonte

Resumo:

Radiotherapy plays an important role in the treatment for thoracic cancers. Accurate diagnosis is essential to correctly perform curative radiotherapy. Tumor delineation is also important to prevent geographic misses in radiotherapy planning. Currently, planning is based on computed tomography (CT) imaging when radiation oncologists manually contour the tumor, and this practice often induces interobserver variability. F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been reported to enable accurate staging and detect tumor extension in several thoracic cancers, such as lung c

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Vendrely, V., E. Rivin Del Campo, A. Modesto, M. Jolnerowski, N. Meillan, S. Chiavassa, A. A. Serre, et al. "Rectal cancer radiotherapy." Cancer/Radiothérapie 26, no. 1-2 (February 2022): 272–78. http://dx.doi.org/10.1016/j.canrad.2021.11.002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

NISHIO, MASAMICHI. "Radiotherapy for Cancer." Journal of the Atomic Energy Society of Japan / Atomic Energy Society of Japan 37, no. 6 (1995): 482–87. http://dx.doi.org/10.3327/jaesj.37.482.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Kunkler, Ian, Nick James, and Jane Maher. "Cancer 2025: Radiotherapy." Expert Review of Anticancer Therapy 4, sup1 (June 2004): S37—S41. http://dx.doi.org/10.1586/14737140.4.5.s37.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Ramsey, Shelileah, and Joel E. Tepper. "Rectal Cancer Radiotherapy." Cancer Journal 13, no. 3 (May 2007): 204–9. http://dx.doi.org/10.1097/ppo.0b013e318074def2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Schratter-Sehn, Annemarie. "Breast cancer radiotherapy." Hamdan Medical Journal 5, no. 1 (2012): 51. http://dx.doi.org/10.4103/2227-2437.231152.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Crha, Tomáš, Luboš Minář, Michal Felsinger, and Vít Weinberger. "Therapeutical strategies for recurrent endometrial cancer." Česká gynekologie 88, no. 4 (August 29, 2023): 302–7. http://dx.doi.org/10.48095/cccg2023302.

Texto completo da fonte

Resumo:

Objective: A comprehensive overview of therapeutical strategies for recurrent endometrial cancer with illustrative case report. Methodology: A review providing basic overview of therapeutical options for different forms of recurrent endometrial cancer including surgical treatment, systemic treatment and radiotherapy. It includes a case report presenting a treatment of patient with an endometrial cancer recurrence in the abdominal wall. Conclusion: Therapeutical strategies in patients with endometrial cancer recurrence include surgical treatment, radiotherapy and systemic treatment depending on

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Sorolla, Maria Alba, Eva Parisi, and Anabel Sorolla. "Determinants of Sensitivity to Radiotherapy in Endometrial Cancer." Cancers 12, no. 7 (July 15, 2020): 1906. http://dx.doi.org/10.3390/cancers12071906.

Texto completo da fonte

Resumo:

Radiotherapy is one of the cornerstone treatments for endometrial cancer and has successfully diminished the risk of local recurrences after surgery. However, a considerable percentage of patients suffers tumor relapse due to radioresistance mechanisms. Knowledge about the molecular determinants that confer radioresistance or radiosensitivity in endometrial cancer is still partial, as opposed to other cancers. In this review, we have highlighted different central cellular signaling pathways and processes that are known to modulate response to radiotherapy in endometrial cancer such as PI3K/AKT

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Woynar, S. P., P. Burban, E. Le Prisé, P. Romestaing, C. Maylin, V. Mazeau, M. Cauterman, and V. Vendrely. "Reducing radiotherapy delays after surgery for breast cancer in five radiotherapy departments." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 17011. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.17011.

Texto completo da fonte

Resumo:

17011 Background: An interval superior to 8 weeks between surgery and radiotherapy increases the risk of recurrence for patients with early stage breast cancer treated with conservative surgery and breast irradiation and without chemotherapy. Five French radiotherapy departments launched simultaneously a quality improvement project aimed at reducing the delay to radiotherapy for all types of cancers concerned. Breast cancer radiotherapy delays were used as the principal proxy to evaluate overall progress. Methods: Teams focused their efforts on reducing the interval between the first appointme

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Bergerot, Paulo Gustavo, Rebecca A. Nelson, Da-Wei Ye, Petros Grivas, Parminder Singh, Neeraj Agarwal, Toni K. Choueiri, and Sumanta K. Pal. "Risk of secondary urinary bladder cancer (UBC) in patients receiving radiotherapy for rectal cancer, prostate cancer, and gynecologic malignancies." Journal of Clinical Oncology 34, no. 2_suppl (January 10, 2016): 363. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.363.

Texto completo da fonte

Resumo:

363 Background: Radiotherapy proximal to the bladder mucosa may incite malignant transformation. We investigated this phenomenon using a large population-based national database. Methods: The SEER13 database from 1992 to 2012 was reviewed for bladder cancer patients who had a history of any previous cancer, including solid tumors and hematologic malignancies. Data regarding the use of radiotherapy was reviewed. Information was analyzed using standardized incidence ratios (SIRs), defined as the ratio of observed to expected cases adjusted by person years at risk. SIRs are considered statistical

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Balakrishnan, M., J. Subhashini, I. Rajesh, and P. Simon. "Radiotherapy Cancer Registry (Hospital Based)." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 141s. http://dx.doi.org/10.1200/jgo.18.77600.

Texto completo da fonte

Resumo:

Background and context: The cancer registry is the information system designed to collect, manage and analyze the data on persons with malignancy (cancer). The objective of the cancer registry is collecting, classifying, evaluation of data and analysis. The purpose of the cancer registry is to identify the incidence, have cancer awareness program and cancer control activities. Aim: To analyze the demography of cancer patients seen at the Department of Radiation Oncology, Christian Medical College (CMC), Vellore, India during the period 2014-2016 and to categorize the data based on age, sex, ty

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Radosevic-Jelic, Ljiljana. "Radio (chemo) therapy in locally advanced rectal cancer." Acta chirurgica Iugoslavica 49, no. 2 (2002): 33–35. http://dx.doi.org/10.2298/aci0202033r.

Texto completo da fonte

Resumo:

Radiotherapy has an role in combined treatment to lower local recurrence in resectable rectal cancer. Radiotherapy also has an established role in nonresectable rectal cancers to increase the operability, but radiochemotherapy is more efficient. Radiotherapy can be administered as a transcutaneous therapy on the megavoltage machines as well as brachytherapy and combined - transcutaneous and brachtherapy.

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Taylor, Carolyn, Candace Correa, Frances K. Duane, Marianne C. Aznar, Stewart J. Anderson, Jonas Bergh, David Dodwell, et al. "Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials." Journal of Clinical Oncology 35, no. 15 (May 20, 2017): 1641–49. http://dx.doi.org/10.1200/jco.2016.72.0722.

Texto completo da fonte

Resumo:

Purpose Radiotherapy reduces the absolute risk of breast cancer mortality by a few percentage points in suitable women but can cause a second cancer or heart disease decades later. We estimated the absolute long-term risks of modern breast cancer radiotherapy. Methods First, a systematic literature review was performed of lung and heart doses in breast cancer regimens published during 2010 to 2015. Second, individual patient data meta-analyses of 40,781 women randomly assigned to breast cancer radiotherapy versus no radiotherapy in 75 trials yielded rate ratios (RRs) for second primary cancers

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

MAEBAYASHI, TOSHIYA, NAOYA ISHIBASHI, TAKUYA AIZAWA, MASAKUNI SAKAGUCHI, KATSUHIKO SATO, TSUYOSHI MATSUI, KENYA YAMAGUCHI, and SATORU TAKAHASHI. "Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients." Anticancer Research 36, no. 9 (September 9, 2016): 4763–70. http://dx.doi.org/10.21873/anticanres.11033.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Domagała-Haduch, Małgorzata, Anita Gorzelak-Magiera, Łukasz Michalecki, and Iwona Gisterek-Grocholska. "Radiochemotherapy in Pancreatic Cancer." Current Oncology 31, no. 6 (June 6, 2024): 3291–300. http://dx.doi.org/10.3390/curroncol31060250.

Texto completo da fonte

Resumo:

Despite the advancements made in oncology in recent years, the treatment of pancreatic cancer remains a challenge. Five-year survival rates for this cancer do not exceed 10%. Among the reasons contributing to poor treatment outcomes are the oligosymptomatic course of the tumor, diagnostic difficulties due to the anatomical location of the organ, and the unique biological features of pancreatic cancer. The mainstay of treatment for resectable cancer is surgery and adjuvant chemotherapy. For unresectable and metastatic cancers, chemotherapy remains the primary method of treatment. At the same ti

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Lahkar, Dhanjit. "Evolution of Radiotherapy- A Brief Review." Journal of Medical Science and clinical Research 12, no. 02 (February 28, 2024): 05–11. http://dx.doi.org/10.18535/jmscr/v12i02.02.

Texto completo da fonte

Resumo:

Beginning with the discovery of X-rays by Wilhelm Conrad Röntgen in 1895 and the subsequent application of X-rays for cancer treatment in 1896, the narrative unfolds through the advancements in radiation therapy modalities. The discussion covers External Beam Radiotherapy (EBRT), including various techniques like 3D-CRT, IMRT, IGRT, stereotactic radiotherapy, and proton therapy. Emerging technologies such as Tomotherapy, Stereotactic Radiosurgery (SRS), Boron Neutron Capture Therapy (BNCT), Carbon Ion Therapy, and Brachytherapy are explored, offering tailored approaches for different cancer ty

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

ONAGA, CHOTARO, SHOMA TAMORI, IZUMI MATSUOKA, AYAKA OZAKI, HITOMI MOTOMURA, YUKA NAGASHIMA, TSUGUMICHI SATO, et al. "High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer." Cancer Diagnosis & Prognosis 2, no. 4 (July 3, 2022): 429–42. http://dx.doi.org/10.21873/cdp.10126.

Texto completo da fonte

Resumo:

Background/Aim: Radiotherapy is one of the main treatments for estrogen receptor-positive (ER+) breast cancer. However, in some ER+ breast cancer cases, radiotherapy is insufficient to inhibit progression and there is a lack of markers to predict radiotherapy insensitivity. Solute carrier family 20 member 1 (SLC20A1) is a sodium/inorganic phosphate symporter, which has been proposed to be a viable prognostic marker for luminal A and B types of ER+ breast cancer. The present study examined the possibility of SLC20A1 as a novel biomarker for the prediction of radiotherapy efficiency. Patients an

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

López Alfonso, Juan Carlos, Jan Poleszczuk, Rachel Walker, Sungjune Kim, Shari Pilon-Thomas, Jose J. Conejo-Garcia, Hatem Soliman, Brian Czerniecki, Louis B. Harrison, and Heiko Enderling. "Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery." JCO Clinical Cancer Informatics, no. 3 (December 2019): 1–16. http://dx.doi.org/10.1200/cci.18.00075.

Texto completo da fonte

Resumo:

PURPOSE Early-stage cancers are routinely treated with surgery followed by radiotherapy (SR). Radiotherapy before surgery (RS) has been widely ignored for some cancers. We evaluate overall survival (OS) and disease-free survival (DFS) with SR and RS for different cancer types and simulate the plausibility of RS- and SR-induced antitumor immunity contributing to outcomes. MATERIALS AND METHODS We analyzed a SEER data set of early-stage cancers treated with SR or RS. OS and DFS were calculated for cancers with sufficient numbers for statistical power (cancers of lung and bronchus, esophagus, rec

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Abraham, Z. S., B. Ngunyale, E. R. Massawe, D. Ntunaguzi, and B. Mpondo. "Oral and Otolaryngological Complications of Radiotherapy for Head and Neck Cancers among Patients attending Ocean Road Cancer Institute, Tanzania." Medical Journal of Zambia 45, no. 1 (July 10, 2018): 32–43. http://dx.doi.org/10.55320/mjz.45.1.113.

Texto completo da fonte

Resumo:

Background: The prevalence of head and neck cancers is on the increase worldwide. Treatment modalities include surgery, radiotherapy and chemotherapy. Radiotherapy with or without chemotherapy affects different parts of the body upon their exposure including the ear, nose, throat and the oral cavity. Data on these complications is scarce. The aim of this study was to determine the proportion of acute oral and otolaryngological complications of radiotherapy with or without chemotherapy for head and neck cancers. Methods: A retrospective cross-sectional, hospital based study was done to 80

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Murthy, Vedang, Sayan Kundu, Tanweer Shahid, Ashwini Budrukkar, Tejpal Gupta, Sarbani Ghosh Laskar, and Jaiprakash Agarwal. "Postoperative Radiotherapy in Head and Neck Cancer." An International Journal of Otorhinolaryngology Clinics 2, no. 1 (2010): 43–51. http://dx.doi.org/10.5005/jp-journals-10003-1016.

Texto completo da fonte

Resumo:

Abstract Though early stage head and neck cancers can be cured either by surgery or radiation, patients with locally advanced disease continues to pose a therapeutic challenge. Locoregional failure is the major cause of death in head and neck cancers. As the outcome of locally advanced head and neck cancer is less than promising, a combined modality approach is generally undertaken in this group of patients. The combination of surgery, radiation and more recently, chemotherapy and targeted therapy can improve outcomes in locally advanced head and neck cancer patients. This overview discusses t

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Abraham, ZS, B. Ngunyale, ER Massawe, D. Ntunaguzi, and B. Mpondo. "Oral and Otolaryngological Complications of Radiotherapy for Head and Neck Cancers among Patients attending Ocean Road Cancer Institute, Tanzania." Medical Journal of Zambia 45, no. 1 (July 11, 2018): 32–43. http://dx.doi.org/10.55320/mjz.45.1.160.

Texto completo da fonte

Resumo:

Background: The prevalence of head and neck cancers is on the increase worldwide. Treatment modalities include surgery, radiotherapy and chemotherapy. Radiotherapy with or without chemotherapy affects different parts of the body upon their exposure including the ear, nose, throat and the oral cavity. Data on these complications is scarce. The aim of this study was to determine the proportion of acute oral and otolaryngological complications of radiotherapy with or without chemotherapy for head and neck cancers.Methods: A retrospective cross-sectional, hospital based study was done to 80 patien

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Wanigasooriya, Kasun, Robert Tyler, Joao D. Barros-Silva, Yashashwi Sinha, Tariq Ismail, and Andrew D. Beggs. "Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors." Cancers 12, no. 5 (May 18, 2020): 1278. http://dx.doi.org/10.3390/cancers12051278.

Texto completo da fonte

Resumo:

Radiotherapy is routinely used as a neoadjuvant, adjuvant or palliative treatment in various cancers. There is significant variation in clinical response to radiotherapy with or without traditional chemotherapy. Patients with a good response to radiotherapy demonstrate better clinical outcomes universally across different cancers. The PI3K/AKT/mTOR pathway upregulation has been linked to radiotherapy resistance. We reviewed the current literature exploring the role of inhibiting targets along this pathway, in enhancing radiotherapy response. We identified several studies using in vitro cancer

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Asadli, Geis. "RADIOTHERAPY IN COMBINED TREATMENT OF RECURRENT STAGE 3 LARYNGEAL CANCER." International Medical Journal, no. 4 (February 26, 2020): 63–66. http://dx.doi.org/10.37436/2308-5274-2019-4-14.

Texto completo da fonte

Resumo:

The paper presents the treatment results performed in 250 patients with a laryngeal tumor of the third stage. The average life expectancy of these patients generally does not exceed 3−6 months. Chemotherapy is usually considered the standard treatment for the recurrence of head and neck squamous cell cancer patients, previously received radiotherapy. When prescribing the chemotherapy, a tumor regression is observed only in 10−40 % and does not virtually affect the life. Average life expectancy of these patients often varies from 5 to 9 months. The optimal total dose of radiotherapy for the tre

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Dona Lemus, Olga Maria, Minsong Cao, Bin Cai, Michael Cummings, and Dandan Zheng. "Adaptive Radiotherapy: Next-Generation Radiotherapy." Cancers 16, no. 6 (March 19, 2024): 1206. http://dx.doi.org/10.3390/cancers16061206.

Texto completo da fonte

Resumo:

Radiotherapy, a crucial technique in cancer therapy, has traditionally relied on the premise of largely unchanging patient anatomy during the treatment course and encompassing uncertainties by target margins. This review introduces adaptive radiotherapy (ART), a notable innovation that addresses anatomy changes and optimizes the therapeutic ratio. ART utilizes advanced imaging techniques such as CT, MRI, and PET to modify the treatment plan based on observed anatomical changes and even biological changes during the course of treatment. The narrative review provides a comprehensive guide on ART

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Gotfrit, Joanna, Rachel Goodwin, Timothy Asmis, Angela J. Hyde, Thierry Alcindor, Francine Aubin, Scott Berry, et al. "Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019." Current Oncology 28, no. 3 (May 26, 2021): 1988–2006. http://dx.doi.org/10.3390/curroncol28030185.

Texto completo da fonte

Resumo:

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19–21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Koo, Tae Ryool, Hong-Gyun Wu, J. Hun Hah, Myung-Whun Sung, Kwang-Hyun Kim, Bhumsuk Keam, Tae Min Kim, et al. "Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer." Cancer Research and Treatment 44, no. 4 (December 31, 2012): 227–34. http://dx.doi.org/10.4143/crt.2012.44.4.227.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Rudan, Ljiljana, Ivanka Marjanov, Slavica Zoranovic, Sonja Petrovic-Stupar, Vesna Plesinac-Karapandzic, Slobodanka Colakovic, Branka Mihajlovic, Radisav Milic, and Slobodan Cikaric. "Cervical cancer (IIB-IVA) radiotherapy vs. radiotherapy + chemotherapy." Archive of Oncology 10, no. 3 (2002): 225. http://dx.doi.org/10.2298/aoo0203225r.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

&NA;. "Paclitaxel + radiotherapy vs radiotherapy alone for lung cancer." Inpharma Weekly &NA;, no. 1561 (October 2006): 13. http://dx.doi.org/10.2165/00128413-200615610-00037.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Jovanović, Marko, Ranković Aleksandar, Suzana Stojanović, and Nenad Milošević. "Kilovoltage radiotherapy as a supportive treatment in locally advanced or metastatic breast cancer – a series of six case reports." International Journal of Radiology & Radiation Therapy 10, no. 1 (February 22, 2023): 16–19. http://dx.doi.org/10.15406/ijrrt.2023.10.00348.

Texto completo da fonte

Resumo:

Kilovoltage (kV) radiotherapy, also called superficial radiotherapy (SXT) or orthovoltage radiotherapy (DXT), is a well-known and effective treatment option for non-melanoma skin cancer and some benign skin and musculoskeletal conditions. Given its surface dose delivery, its use in radiation oncology beyond superficial skin cancers is generally limited, but it has also been shown to be extremely useful for specific palliative applications. Here, we describe the characteristics of kilovoltage radiotherapy and report on six cases of locally advanced and/or metastatic breast cancer in which kilov

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

White, Julia. "Do We Need to Irradiate All Small Invasive Breast Cancers and DCIS?" American Society of Clinical Oncology Educational Book, no. 33 (May 2013): 40–44. http://dx.doi.org/10.14694/edbook_am.2013.33.40.

Texto completo da fonte

Resumo:

Breast radiotherapy after lumpectomy is considered standard for nearly all patients with invasive breast cancer and is recommended for many patients after lumpectomy for ductal carcinoma in situ (DCIS). However, there is recognition that lumpectomy alone can achieve optimal cancer control for some patients with invasive breast cancer and DCIS. Patients with breast cancers with lower risk of recurrence are less likely to derive benefit from breast radiotherapy. This review will focus on defining populations of patients with invasive breast cancer and DCIS with a low risk of recurrence post-lump

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Pountney, David. "Controversial breast cancer radiotherapy." Cancer Nursing Practice 2, no. 4 (May 2003): 6–7. http://dx.doi.org/10.7748/cnp.2.4.6.s7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Chang, Hye Sook. "Radiotherapy for Lung Cancer." Tuberculosis and Respiratory Diseases 37, no. 3 (September 1, 1990): 249–57. http://dx.doi.org/10.4046/trd.1990.37.3.249.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Dische, Stanley. "Radiotherapy of Cervical Cancer." Clinics in Obstetrics and Gynaecology 12, no. 1 (March 1985): 203–27. http://dx.doi.org/10.1016/s0306-3356(21)00103-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Chargari, C., K. Peignaux, A. Escande, S. Renard, C. Lafond, A. Petit, J. M. Hannoun-Lévi, C. Durdux, and C. Haie-Méder. "Radiotherapy for endometrial cancer." Cancer/Radiothérapie 26, no. 1-2 (February 2022): 309–14. http://dx.doi.org/10.1016/j.canrad.2021.11.016.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Blanchard, P., J. Biau, F. Huguet, S. Racadot, C. Berthold, S. Wong-Hee-Kam, M. C. Biston, and P. Maingon. "Radiotherapy for nasopharyngeal cancer." Cancer/Radiothérapie 26, no. 1-2 (February 2022): 168–73. http://dx.doi.org/10.1016/j.canrad.2021.08.009.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Cvek, Jakub, Iveta Halfarová, Lukáš Molenda, and Lukáš Knybel. "Non-cancer external radiotherapy." Onkologie 14, no. 6 (January 8, 2021): 278–81. http://dx.doi.org/10.36290/xon.2020.093.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Gruzdev, V. S. "Radiotherapy for uterine cancer." Kazan medical journal 18, no. 1 (September 20, 2021): 103–28. http://dx.doi.org/10.17816/kazmj79638.

Texto completo da fonte

Resumo:

Usually, it is customary to take any broad, general questions of medicine as topics for speeches delivered at the Annual Meetings of our Society. In deviation from this rule, the subject of my speech will be only a private medical method, and, moreover, applied to a particular disease of one organ. If, however, I add that such a disease is uterine cancer, and the therapeutic method, which I will talk about in my speech, is radiation therapy, then the indicated digression will become completely understandable for you.

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Park, Won. "Radiotherapy for prostate cancer." Journal of the Korean Medical Association 58, no. 1 (2015): 21. http://dx.doi.org/10.5124/jkma.2015.58.1.21.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Suh, Chang-Ok. "Radiotherapy for Breast Cancer." Journal of the Korean Medical Association 46, no. 6 (2003): 503. http://dx.doi.org/10.5124/jkma.2003.46.6.503.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Prosnitz, Leonard R. "Radiotherapy for Lung Cancer." Annals of Internal Medicine 114, no. 1 (January 1, 1991): 95. http://dx.doi.org/10.7326/0003-4819-114-1-95.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Cuzick, J. "Radiotherapy for Breast Cancer." JNCI Journal of the National Cancer Institute 97, no. 6 (March 15, 2005): 406–7. http://dx.doi.org/10.1093/jnci/dji086.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!